NFKB1 and amyotrophic lateral sclerosis: Collectively, our findings demonstrate that the ALS-linked FUSR521G mutant causes cell-autonomous defects that contribute to ALS/FTD-associated pathologies, and that targeting the canonical NF-κB pathway is a therapeutic strategy for attenuating gliosis and maintaining corticospinal connectivity in ALS/FTD.